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Abstract
Introduction: We assessed the magnitude of smokeless tobacco (ST) use in Pakistan and identi-
ied policy gaps to help ascertain short-, medium-, and long-term priorities. We then elicited stake-
holders’ views as to which of these identiied priorities are most important.
Methods: In a multimethod study, we: analyzed Global Tobacco Surveillance System data sets to 
estimate ST consumption and disease burden; conducted a documentary review to identify gaps 
in policies to control ST in comparison with smoking; elicited stakeholders’ views in an interactive 
workshop to identify a set of policy options available to address ST burden in Pakistan; and ranked 
policy priorities using a postevent survey.
Results: Among all tobacco users in Pakistan (n = 24 million), one-third of men and two-thirds of 
women consume ST. In 2017, its use led to an estimated 18 711 deaths due to cancer and ischemic 
heart disease. Compared to smoking, policies to control ST lag behind signiicantly. Priority areas 
for ST policies included: banning ST sale to and by minors, advocacy campaigns, introduction of 
licensing, levying taxes on ST, and standardizing ST packaging. A clear commitment to close co-
operation between state actors and stakeholder groups is needed to create a climate of support 
and information for effective policy making.
Conclusions: Smokeless tobacco control in Pakistan should focus on four key policy instruments: 
legislation, education, iscal policies, and quit support. More research into the effectiveness of such 
policies is also needed.
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/n
tr/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/n
tr/n
tz
1
6
3
/5
5
5
6
4
7
8
 b
y
 g
u
e
s
t o
n
 0
9
 O
c
to
b
e
r 2
0
1
9
2 Nicotine & Tobacco Research, 2019, Vol. XX, No. XX
Implications: A number of opportunities to improve ST regulation in Pakistan were identiied. 
Among these, immediate priorities include banning ST sale to and by minors, mobilizing advocacy 
campaign, introduction of licensing through the 1958 Tobacco Vendors Act, levying taxes on ST, 
and standardizing ST packaging.
Introduction
Smokeless tobacco (ST) is consumed by approximately 356 million 
people (one-fourth of all tobacco users) in 140 countries.1 In 29 of 
these countries, more than 10% of the population uses ST regu-
larly.2 Regulated poorly,2 ST products vary in their composition and 
health risks. Most of these products, particularly in low- and middle-
income countries (LMICs),3 contain high levels of nicotine and ni-
trosamines, leading to dependence and a high incidence of head and 
neck cancers, respectively.4 ST products are also associated with car-
diovascular deaths5 and, if consumed during pregnancy, with poor 
birth outcomes.6 The burden of disease due to ST use is particularly 
high in Asia and Africa,3,7 where the poorest sectors of society bear 
the greatest burden.1
Despite being signatories to the World Health Organization 
(WHO) Framework Convention for Tobacco Control (FCTC), there 
is substantial disparity in policy development and implementation be-
tween smoking and ST products.2 As a consequence, progress to curb 
ST consumption is falling behind that for smoking.2 In Pakistan—a 
high tobacco burden country—ST products are popular, cheap, and 
easily available.8 Unlike cigarettes, ST consumption is also common 
and socially acceptable among women and young people.9 Recently, 
several academics, civil society organizations, and statutory bodies 
from Pakistan have joined a new initiative called Addressing ST and 
building Research capacity in south Asia (ASTRA).10 On behalf of 
ASTRA, we conducted a multimethod analysis to identify policy chal-
lenges, opportunities, and priorities to improve its regulation.
Methods
We: (1) analyzed secondary data to describe ST use prevalence and 
estimate its disease burden; (2) reviewed documents to compare 
policies for controlling ST with those for smoking; (3) convened 
an interactive consultation to elicit stakeholders’ views to identify 
a set of policy options available to address ST; and (4) conducted a 
postevent survey to determine the most important policy priorities.
Secondary Data Analysis
We analyzed Global Adult Tobacco Survey11 (GATS) 2014 and 
Global Youth Tobacco Survey12 (GYTS) 2013 to compare distribu-
tions of ST use with smoking. The disease burden attributable to ST 
use was estimated as a proportion of the burden reported in the 2017 
Global Burden of Disease study.13 For this, we used comparative risk 
assessment method—also used previously to estimate global burden 
of disease due to ST.3 Exposure to ST was extrapolated from GATS,11 
and disease-speciic risk estimates for cancers and cardiovascular dis-
eases were obtained from previously published meta-analyses.3,5
Documentary Review
We undertook a comparative documentary review to highlight differ-
ences in policies between smoking and ST. We reviewed all tobacco-
related legislative documents and Statutory Regulatory Orders 
(SROs) issued in the last 20 years by the then Ministry of Health and 
Ministry of National Health Services, Regulations and Coordination 
Pakistan (NHSRC).14 We also reviewed summaries of the legislation 
available on tobacco control laws web site.15 Moreover, we analyzed 
GATS11 data to assess the extent to which advice and support is 
offered to ST users in comparison with smokers.
Priority Setting Workshop
We shared the indings of the above two studies at a 2-day stake-
holders’ workshop. We invited a total of 28 policy makers, aca-
demics, and advocates at this event and organized discussions 
around ive themes:16 iscal policies, product regulation, education 
and awareness, cessation support, and knowledge gaps. Following 
the initial brainstorming and discussion at the event, a consensus 
development approach was undertaken to identify and agree on key 
priorities to address ST use. After the event, the key priorities were 
shared with all 28 stakeholders for feedback.
Postevent Survey
Postworkshop, the stakeholders used an online survey to rank 
these policies on a ive-point scale in terms of their priority level. 
Stakeholder’s responses were pooled to generate mean scores for the 
policy options and ranked accordingly.
Results
Prevalence of ST Use and Associated Disease Burden
Over 9.6 million adults (7.7% overall, 11.4% males, 3.7% females) 
in Pakistan consume ST regularly; this constitutes approximately 
one-third (35.6%) of all male tobacco users and up to two-thirds 
(62.8%) of all females’ tobacco users. Among adolescents aged 
13–15 years, up to 54.0% of tobacco users consume ST, with es-
timates of current use being 6.4% and 3.7% in males and females, 
respectively. Naswar is by far the most commonly used ST product, 
followed by tobacco containing paan and gutkha.
The overall disease burden attributable to ST was based on 
the risk of mouth (relative risk [RR] 5.2), pharyngeal (RR 2.6) 
and esophageal (RR 2.6) cancers, and ischemic heart disease (RR 
1.57).3 We estimated that, in 2017, approximately 18  711 deaths 
and 200 638 disability-adjusted life years (DALYs) in Pakistan were 
attributed to ST users. A third of this disease burden was estimated 
to be due to cancers and two-thirds due to ischemic heart disease.
Policy Gaps in Relation to ST
Table 1 lists the tobacco control laws in Pakistan, identifying the 
differences between smoking and ST. Other than restricting general 
advertisement and sale within the vicinity of educational institu-
tions, all other laws have not been applied to ST, indicating a wide 
disparity in the way the two types of tobacco use are dealt with. 
Further analysis of GATS results (Figure 1) found that health pro-
fessionals are less likely to inquire about individuals’ ST use as com-
pared to cigarette use and also less likely to offer advice, behavioral 
support, or medication to help them quit (Figure 1). On the other 
hand, knowledge and awareness of health-related harms of tobacco 
use were lower among ST users (77.0%) than in smokers (86.0%).
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Barriers and Opportunities
In the stakeholders’ workshop (attended by 19/28 invitees), there 
was acknowledgment of the gaps in ST regulations and the need to 
reduce ST-related burden. Participants recognized that ST is manu-
factured primarily in the informal sector in Pakistan, which made it 
challenging to tax and regulate. However, unlike cigarettes, this also 
made any direct industry interference less likely in response to any 
policy action(s). Other barriers included lack of awareness of the 
ST-related health risks among policy makers and legislators, vari-
ations in packaging of ST products, little understanding of its supply 
chain, and an absence of evidence on cessation strategies. It was also 
recognized that, over the long term, policies to reduce ST use should 
include encouraging alternative livelihoods for producers.
Policy Priorities
The following priorities were identiied (and ranked by 20/28):
 1. Fiscal policies: Ninety percent considered the enactment of the 
1958 Tobacco Vendor Act that mandates licensing for all tobacco 
sellers as high priority. Seventy-ive percent considered levying 
taxes at a minimum of 70% of the retail price, implementing tax 
track and trace and earmarking tobacco tax for providing alter-
native livelihoods as high priorities.
 2. Cessation services: There was a signiicant majority of partici-
pants who considered the formulation of national guidelines 
for treating tobacco dependence (80%), integrating tobacco de-
pendence treatment within existing health systems (75%), and 
incorporating it within health professionals’ curriculum (70%) 
should receive high priority. A comprehensive service to treat to-
bacco dependence was considered a long-term goal.
 3. Education and awareness: A  comprehensive media campaign 
to raise public awareness about ST (90%) and building an 
antitobacco advocacy coalition of legislators, health profes-
sional, journalists, cancer charities, and patient support groups 
should be the highest priority (90%), followed by antitobacco 
messages within educational institutions and curricula (80%).
 4. Product regulation: Everyone agreed that a ban on ST product 
sale to and by minors should be introduced immediately. Seventy 
percent considered standardizing ST packaging and labeling 
including mandating pictorial warnings and formalizing industry 
by introducing licensing should be a high priority. It was agreed 
that manufacturers requiring disclosure of their ingredients and 
regular inspections and laboratory testing could be introduced at 
a later stage.
 5. Research priorities: These included an estimation of the eco-
nomic and disease burden of ST use and the return on investment 
in addressing it. Others included documenting all ST products 
and their composition available in Pakistan, their market share, 
and points in the supply chain where taxes can be levied.
Discussion
ST products are commonly used in Pakistan and impact different 
segments of population, including women and people of low 
socioeconomic status. Products consumed are known to contain high 
levels of nicotine and nitrosamines, which are linked to wide-ranging 
harms including speciic types of cancers (head and neck), cardiovas-
cular diseases, and poor perinatal outcomes. The proile of ST prod-
ucts in Pakistan is in contrast with those in Nordic countries, where 
available ST products have low nitrosamine levels and pose fewer 
health risks.17 Moreover, unlike smoking, ST has received little at-
tention so far. This is the irst priority setting exercise that we know 
of to provide a list of policy actions to address ST use in Pakistan.
Among all 140 countries where ST is consumed, Pakistan is 
among the top three countries with the highest ST-related disease 
burden, superseded only by India and Bangladesh.3 A recent global 
policy review2 highlighted that a majority of the 140 countries have 
not yet put comprehensive tobacco control measures covering ST 
use in place. Only a handful of countries levy taxes up to 70% of 
their retail price, inspect their contents, ban advertising, or warn 
their populations of ST-related harms. That said, Pakistan could 
learn lesson from India where some policy action has happened to 
curb ST use, including effective advocacy led by civil society in India, 
leading to the introduction of strong pictorial warnings, use of Food 
Safety and Standards Act, 2006, to ban gutkha sale, levying tax on 
ST manufacturing units, and prohibiting ST use as an ingredient 
within tooth cleaning products.18
Limitations
Our disease burden igures are conservative and are derived from risk 
estimates based on ST use in Pakistan and other countries.3,5 The stake-
holders’ views included in this study come from a nonrandom sample 
Table 1. A comparative analysis of tobacco control laws in 
Pakistan for both smoking and smokeless tobacco
Tobacco control laws in Pakistan Smoking
Smokeless 
tobacco
Requirements to have nicotine and tar contents 
on the label
No No
Requirements to have excise stamp, afixing 
banderols on the pack
No No
Prohibition on quantity, i.e., sale less than 20 
per pack
Yes No
Smoke-free laws Yes Not 
applicable
Warning labels on packs Yes No
Restriction on advertisement of tobacco Yes Yes
Promotion of samples to minors Yes No
Prohibition of sale of tobacco to minors and by 
minors
Yes No
Prohibition of storage, sale, and distribution 
of tobacco in the immediate vicinity of 
educational institutions 
Yes Yes
0 10 20 30 40 50
% visited health worker in last 12…
% asked about tobacco use
% advised to quit
% advised to quit on their own
% oﬀered behavioural support
% oﬀered medicaon
% oﬀered other support
smokeless tobacco smokers
Figure 1. A comparison between smokers and smokeless tobacco users in 
the way they are advised by health professionals in the last 12 months.
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of workshop and postevent survey participants. They include a cross 
section of wider stakeholder group (health advocates, health care pro-
viders, and researchers) within Pakistan’s health sector. Policy makers’ 
views may be underrepresented; this is a gap ASTRA will address in 
the near future. However, the policy elicitation process was facilitated 
by international experts and supported by health professionals from 
Pakistan who are knowledgeable and experienced in the ield. Despite 
its limitations, it constitutes the irst initiative to consolidate and coord-
inate research and advocacy expertise in ST use in Pakistan.
Implications
The policy priorities identiied in our analysis are similar to global 
priorities for ST,2 for example, taxation, standardization of packaging, 
educational campaigns, training health professionals in treating ST de-
pendence, preventing the sale by and to minors, and monitoring the 
health and economic impact. Were even some of these policies to be 
adopted, it is likely that the impact of ST on health outcomes would 
be reduced, though research will, of course, be needed to establish 
which interventions produce the most signiicant health impact. With 
this in mind, the above analysis was also useful in orientating ASTRA’s 
future research direction in line with the knowledge gaps identiied 
by the stakeholders and in building capacity and generating demand 
for further research—one of ASTRA’s objectives. For all affected com-
munities, it is hoped that this exercise will generate momentum for a 
multisectorial effort to address ST as a public health issue.
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